Status:
COMPLETED
Effect of Dietary Inflammatory Index on Inflammatory Markers and Metabolic Parameters, in Patients With Type 2 Diabetes Mellitus
Lead Sponsor:
Istanbul University
Conditions:
Type 2 Diabetes
Dietary Inflammatory Index (DII)
Eligibility:
All Genders
30-74 years
Brief Summary
Nutrition is essential in the treatment and management of Type 2 Diabetes. The importance of adding foods with anti-inflammatory effects to daily diet plans in ensuring glycemic control, preventing th...
Detailed Description
Nutrition is one of the most important determinants of inflammation. When the results of the studies were examined, it was seen that the diet was associated with inflammation in chronic diseases. It w...
Eligibility Criteria
Inclusion
- Patients with a diagnosis of Type 2 Diabetes Mellitus and HbA1c ≤ 7%
- Patients using or not using oral antidiabetic drugs
- Patients who inject insulin once or twice a day or repeated insulin injections
Exclusion
- Patients diagnosed with Type I Diabetes Mellitus,
- Patients with HbA1c \> 7%
- Those with gestational diabetes,
- Breastfeeding diabetics,
- Patients with renal dysfunction,
- Patients with acute and chronic infection status
Key Trial Info
Start Date :
November 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2020
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05271695
Start Date
November 1 2019
End Date
April 1 2020
Last Update
March 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul University, Faculty of Medicine, Department of Endocrinology and Metabolism
Istanbul, Capa, Turkey (Türkiye), 34093